Smith Anderson advised Wolfspeed on the deal. Wolfspeed (NYSE: WOLF), the world’s largest producer of silicon carbide technology, has signed a non-binding Preliminary Memorandum of Terms...
Wolfspeed’s $750 Million Proposed Funding for Silicon Carbide Expansion
PROOF’s $50 Million Series A Financing
Gunderson Dettmer represented Andreessen Horowitz on the deal. Andreessen Horowitz (a16z) led the $50 million Series A financing of PROOF, an operator of media, podcasts, and...
Afresh’s $115 Million Series B Financing
Gunderson Dettmer represented Spark Capital on the deal. Spark Capital led the $115 million Series B financing of Afresh, an AI-powered fresh food technology provider that...
GoCardless’ Acquisition of Nordigen
Sorainen advised Nordigen on the deal, while GoCardless was advised by Ellex and Fenwick. Nordigen, a freemium open banking data provider from Latvia, in a transaction...
Remix Therapeutics’ $70 Million Series B Financing
Gunderson Dettmer advised Remix Therapeutics on the deal. Remix Therapeutics, a Massachusetts-based biotech company, announced its $70 million Series B financing which included participation from Surveyor, Foresite...
GoCardless’ $312 Million Series G Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised GoCardless on the deal. GoCardless, a direct payment solutions platform, announced its $312 million Series G financing led...
Interline Therapeutics’ $92 million Series Seed and Series A financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Interline Therapeutics on the deal. Interline Therapeutics, a data science and healthcare company, announced its $92 million Series...
Pyxis Oncology’s $152M Series B Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Pyxis Oncology on the deal. Pyxis Oncology (“Pyxis” or the “Company”) announced the closing of a $152 million...